Results 31 to 40 of about 23,500 (271)

Ocular Manifestations of Candidemia [PDF]

Clinical Infectious Diseases, 2011
Ocular candidiasis is a major complication of candidemia. The incidence, risk factors, and outcome of eye involvement during candidemia are largely unknown. We prospectively studied the ocular manifestations of candidemia in a large, worldwide, randomized multicenter trial that compared voriconazole with amphotericin B followed by fluconazole for the ...
Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, VISCOLI, CLAUDIO, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ   +9 more
openaire   +2 more sources

Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia

Diagnostics, 2023
There is increasing interest in assessing whether machine learning (ML) techniques could further improve the early diagnosis of candidemia among patients with a consistent clinical picture.
Daniele Roberto Giacobbe, Sara Mora, Alessio Signori, Chiara Russo, Giorgia Brucci, Cristina Campi, Sabrina Guastavino, Cristina Marelli, Alessandro Limongelli, Antonio Vena, Malgorzata Mikulska, Anna Marchese, Antonio Di Biagio, Mauro Giacomini, Matteo Bassetti   +14 more
doaj   +1 more source

Persistent candidemia in very low birth weight neonates: risk factors and clinical significance

BMC Infectious Diseases, 2018
Background The prevalence and risk factors for persistent candidemia among very low birth weight infants are poorly understood. This study aimed to investigate the epidemiology of persistent candidemia over a 4-year period in a neonatal intensive care ...
Jinjian Fu, Yanling Ding, Yongjiang Jiang, Shengfu Mo, Shaolin Xu, Peixu Qin   +5 more
doaj   +1 more source

Risk Factors and Clinical Outcomes of Candidemia Associated With Severe COVID-19

Critical Care Explorations, 2022
IMPORTANCE:. COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of fungal infections, including candidemia following severe COVID-19 though understanding
Deepali Dixit, PharmD, BCPS, BCCCP, FCCM, Polly Jen, PharmD, BCPS, BCIDP, AAHIVP, Tyler D. Maxwell, BS, PharmD, Steven Smoke, PharmD, BCPS, BCIDP, James Andrew McCracken, PharmD, Maria Cardinale-King, PharmD, BCCCP, Aditi Haribhakti, PharmD Candidate, Purvi Patel, MD, Eris Cani, BS, PharmD, BCIDP, BCPS, Seohyun (Claudia) Choi, PharmD, BCCCP, Sugeet Jagpal, MD, Tilly Varughese, MD, Luis L. Tatem, MD, Tanaya Bhowmick, MD   +13 more
doaj   +1 more source

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]

, 2013
Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Ballus, Jose, Bingold, Tobias Michael, Kaskel, Peter, Krobot, Karl J., Kumar, Ritesh N., Mavros, Panagiotis, Nocea, Gonzalo, Wissing, Heimo   +7 more
core   +1 more source

Candida auris: a decade of understanding of an enigmatic pathogenic yeast [PDF]

, 2020
Candida auris is an enigmatic yeast that continues to stimulate interest within the mycology community due its rapid and simultaneous emergence of distinct clades.
Brown, Jason, Gulmez, Dolunay, Kean, Ryan, Ramage, Gordon, Ware, Alicia   +4 more
core   +2 more sources

Clinical Outcomes of Intra-Abdominal Candidiasis by Initial Antifungal Therapy. [PDF]

Mycoses
ABSTRACT Background Intra‐abdominal candidiasis (IAC) is a severe and heterogeneous infection associated with significant morbidity and mortality. Objectives To evaluate outcomes of IAC according to initial antifungal therapy and to identify predictors of persistent infection and 30‐day mortality.
Albanell-Fernández M, Vergara A, Marco F, Herrera S, Tuset M, Soriano A, Bodro M.   +6 more
europepmc   +2 more sources

Candida auris, what do paediatricians need to know? [PDF]

, 2018
AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen.Peer reviewedPublisher ...
Warris, Adilia
core   +1 more source

A Prospective Surveillance Study of Candidaemia : Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients [PDF]

, 2016
Funding This work was supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377/Z/11/Z. Data collection was supported by a grant from Pfizer.
Deshpande, Ashutosh, Hanson, Mary F., Johnson, Elizabeth M., Jones, Brian L., Munro, Carol A., Rajendran, Ranjith, Ramage, Gordon, Sherry, Leighann, Williams, Craig   +8 more
core   +2 more sources

Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit

Journal of Fungi, 2022
Serum beta-D-glucan (BDG) determination plays an important role in the diagnosis of candidemia among critically ill patients admitted to the intensive care unit (ICU). However, BDG levels measured may be lower in the case of infections caused by some non-
Malgorzata Mikulska, Laura Magnasco, Alessio Signori, Chiara Sepulcri, Silvia Dettori, Stefania Tutino, Antonio Vena, Franca Miletich, Nadir Ullah, Paola Morici, Lorenzo Ball, Paolo Pelosi, Anna Marchese, Daniele Roberto Giacobbe, Matteo Bassetti   +14 more
doaj   +1 more source